Raily Aesthetic Medicine International Holdings Limited (HKG:2135)

HKG:2135 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	219.59	189.41	199.34	189.38	164.52	188.37
Revenue Growth	15.93%	-4.98%	5.26%	15.11%	-12.66%	14.48%
Gross Profit Gross Profit Growth	92.65	77.71	71.41	71.49	66.78	69.69
Operating Income Operating Income Growth	18.66	5.18	-18.87	-22.52	-20.39	-19.57
Net Income Net Income Growth	13.54	1.87	-59.21	-32.46	-15.91	-17.69
Earnings Per Share EPS Growth	0.02	0.00	-0.11	-0.08	-0.04	-0.04
EPS Growth	624.87%	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Aesthetic Medical Services Aesthetic Medical Services Growth	152.91	142.1	174.91	151.66	183.71
Aesthetic Medical Equipment Products Aesthetic Medical Equipment Products Growth	39.26	59.08	15.22	14.21	1.65
Consulting Services Consulting Services Growth	3.67	0.03	-	0.03	3.17
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth	-6.43	-1.87	-0.75	-1.38	-0.17
Total Total Growth	189.41	199.34	189.38	164.52	188.37

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	48.67	57.79	28.87	39.79	78.78	124.89
Total Debt Total Debt Growth	49.85	59.15	56.37	51.78	48.22	67.45
Net Cash (Debt) Net Cash Growth	-1.17	-1.36	-27.5	-11.99	30.56	57.44
Net Cash Growth	-	-	-	-	-46.80%	-56.88%
Net Cash Per Share Net Cash Per Share Growth	-0.00	-0.00	-0.05	-0.03	0.07	0.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-	36.71	6.01	8.02	-2.28	-2.47
Capital Expenditures CapEx Growth	-	-2.73	-8.64	-18	-18.85	-15.77
Free Cash Flow Free Cash Flow Growth	-	33.98	-2.64	-9.98	-21.13	-18.23
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	42.19%	41.03%	35.82%	37.75%	40.59%	37.00%
Operating Margin	8.50%	2.73%	-9.47%	-11.89%	-12.39%	-10.39%
Pretax Margin	6.18%	0.01%	-32.74%	-18.49%	-13.43%	-12.18%
Profit Margin	6.17%	0.99%	-29.70%	-17.14%	-9.67%	-9.39%
FCF Margin	-	17.94%	-1.32%	-5.27%	-12.84%	-9.68%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	4.27	40.09	-	-	-	-
P/FCF Ratio	-	2.21	-	-	-	-
PS Ratio	0.26	0.40	0.28	0.96	1.76	2.67

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error